BIO
Bio-Rad Laboratories, Inc.
Stock
$369.14+13.57 (+3.82%)Close Oct 2, 2026
- Operating cash flow, 2025
- $532M
- YoY, 2025
- +16.9%
- 5-year CAGR
- −1.9%
- 10-year CAGR
- +11.1%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $532M | +16.9% |
| 2024 | $455M | +21.4% |
| 2023 | $375M | +92.8% |
| 2022 | $194M | −71.0% |
| 2021 | $669M | +14.4% |
| 2020 | $585M | +27.8% |
| 2019 | $458M | +60.4% |
| 2018 | $285M | +174.2% |
| 2017 | $104M | −51.8% |
| 2016 | $216M | +16.0% |
| 2015 | $186M | −31.9% |
| 2014 | $273M | +61.6% |
| 2013 | $169M | −36.5% |
| 2012 | $266M | +1.4% |
| 2011 | $263M | +16.3% |
| 2010 | $226M | −30.5% |
| 2009 | $325M | +69.9% |
| 2008 | $191M | — |